Wei Wen Hou

Director/Board Member en MingMed Biotechnology Co., Ltd. .

49 años

Consumer Services

Health Technology

Perfil

Wei Wen Hou is currently an Independent Non-Executive Director at MingMed Biotechnology Co., Ltd.
He completed his undergraduate degree at The Chinese University of Hong Kong in 1997 and earned an MBA from The Hong Kong University of Science & Technology in 2007.

Cargos activos de Wei Wen Hou

Empresas	Cargo	Inicio
MingMed Biotechnology Co., Ltd. MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China.	Director/Board Member	-

Todos los cargos activos de Wei Wen Hou

Formación de Wei Wen Hou.

The Chinese University of Hong Kong	Undergraduate Degree
The Hong Kong University of Science & Technology	Masters Business Admin

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Wei Wen Hou.

Relaciones

100 +

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	1
MingMed Biotechnology Co., Ltd. MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China.	Health Technology